News
Videos
Conferences
Events
Resources
Subscribe

|Videos|January 31, 2016

Interventional Radiologist's Role

Episodes in this series

EP. 1 Freda's Story: Her Diagnosis of CRC

EP. 1 Freda's Story: Her Diagnosis of CRC

EP. 2 Interventional Radiologist's Role

EP. 2 Interventional Radiologist's Role

EP. 3 Considering a Second Opinion for Cancer Care

EP. 3 Considering a Second Opinion for Cancer Care

EP. 4 It Takes a Team to Treat Cancer

EP. 4 It Takes a Team to Treat Cancer

EP. 5 Treatment of Metastatic Colorectal Cancer

EP. 5 Treatment of Metastatic Colorectal Cancer

EP. 6 Clinical Trials for Cancer Treatment

EP. 6 Clinical Trials for Cancer Treatment

EP. 7 Improving Care For Patients

EP. 7 Improving Care For Patients

EP. 8 Freda: Managing Aggressive Treatment

EP. 8 Freda: Managing Aggressive Treatment

EP. 9 Finding the Right Treatment Option

EP. 9 Finding the Right Treatment Option

EP. 10 How to Pay for Treatment Options

EP. 10 How to Pay for Treatment Options

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Mary Royal and Dr. Pablo Prichard

MRD Testing May Offer Peace of Mind to Breast Cancer Survivors

ByMary Royal,Dr. Pablo Prichard

February 11th 2026

In an interview, liver cancer survivor Charles Walker shared how family support and a living donor transplant changed his treatment journey and outlook.

A Family’s Strength Through Liver Cancer and Living Donation

February 11th 2026

Charles Walker joins CURE’s Gina Mauro.

From Missed Signs to Second Chances After a Liver Cancer Diagnosis

February 10th 2026

The FDA granted fast track designation to irpagratinib for previously treated advanced hepatocellular carcinoma with FGF19 overexpression.

FDA Fast Track Designation Highlights New Option in Advanced Liver Cancer

February 10th 2026

Mary Royal

Mom of Four Shares Story of Her Breast Cancer Diagnosis

February 9th 2026

Trending on CURE

Keytruda Combo Approved for Platinum-Resistant Ovarian Cancer

FDA Grants Designation to Immunotherapy KB707 for Advanced NSCLC

Why Subcutaneous Darzalex Faspro Matters for Patients With Multiple Myeloma

FDA Clears Phase 2b Study of Teverelix in Advanced Prostate Cancer

FDA Fast Track Designation Highlights New Option in Advanced Liver Cancer